MARLBOROUGH, Mass.–(BUSINESS WIRE)–#JPMorganconference–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 11:40 a.m. Eastern Time.
The presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com
SOURCE: Hologic, Inc.
Contacts
Paula Izidoro
Senior Investor Relations Specialist
(858) 410-8904
paula.izidoro@hologic.com
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…
